Viewing Study NCT02128334


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2026-01-07 @ 7:33 PM
Study NCT ID: NCT02128334
Status: COMPLETED
Last Update Posted: 2016-08-16
First Post: 2014-04-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation
Sponsor: Astellas Pharma Europe B.V.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module